文献速递骨肌技术与安全MR

钆在大鼠皮肤中的存留:与小纤维神经病相关组织病理学改变的评估

Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy.
PubMed 文献 · Radiology · 2024-01-01

研究对50只大鼠给予8次静脉注射钆布醇、钆特酸、钆特醇、钆双胺或生理盐水,在末次注射后5天或5周评估足垫表皮内神经纤维密度(IENFD)及皮肤钆浓度与形态。结果各钆剂组IENFD与生理盐水组均无显著差异,未见小纤维神经病征象;钆双胺皮肤钆浓度最高,大环类钆剂皮肤钆浓度较低且5周内有效清除,汗腺中检出完整大环螯合物。

要点

  • 大鼠多次给予钆剂后足垫IENFD与生理盐水组无显著差异,未见小纤维神经病征象。
  • 钆双胺皮肤钆浓度最高(5天16.0 nmol/g,5周10.6 nmol/g,下降33%)。
  • 大环类钆剂皮肤钆浓度较低,5周内有效清除(钆特醇下降95%,钆布醇和钆特酸下降96%)。

核心结论

  • 大鼠足垫在多次给予钆剂后两个时间点均未见小纤维神经病征象;与线性钆双胺相比,大环类钆剂皮肤钆水平更低且在5周内有效清除,汗腺中检出完整大环钆剂。

研究设计与样本

  • 动物实验:50只大鼠接受8次静脉注射钆双胺、钆布醇、钆特酸、钆特醇(8×0.6 mmol/kg体重)或生理盐水(1.2 mL/kg体重),2周内完成,末次注射后5天或5周处死;以PGP9.5免疫荧光染色和盲法自动图像分析测定IENFD,以ICP-MS、激光剥蚀ICP-MS和MALDI MSI测定钆及钆剂浓度。

关键影像表现/征象

  • 钆分布与IENF分布视觉上不重叠。
  • 大环类钆剂组钆见于汗腺,并证实为完整螯合物。

诊断标准与关键数值

  • IENFD以几何均值(SD)表示、单位为每毫米表皮神经纤维数:5天时生理盐水8.4(1.1)、钆布醇9.7(1.2)、钆特酸9.2(1.2)、钆特醇9.9(1.3)、钆双胺10.5(1.2),均无显著改变。
  • 5周时IENFD:生理盐水19.7(1.4)、钆布醇16.4(1.6)、钆特酸14.3(1.6)、钆特醇22.2(1.8)、钆双胺17.9(1.4),均无显著改变。
  • 皮肤钆浓度5天时钆双胺16.0 nmol/g(1.1)最高,钆特醇2.6 nmol/g(1.2)、钆布醇2.7 nmol/g(1.1)、钆特酸2.3 nmol/g(1.2)较低。
  • 皮肤钆浓度5周时钆双胺10.6 nmol/g(1.2,下降33%);钆特醇下降95%,钆布醇和钆特酸下降96%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The presence of gadolinium traces in the skin after administration of gadolinium-based contrast agents (GBCAs) raised safety concerns regarding a potential association with small fiber neuropathy (SFN). Purpose To investigate signs of SFN in rat foot pads by quantification of the intraepidermal nerve fiber density (IENFD) after multiple GBCA administrations and to evaluate gadolinium concentration, chemical species, and clearance. Materials and Methods Fifty rats received eight intravenous injections of either gadodiamide, gadobutrol, gadoterate, gadoteridol (8 × 0.6 mmol per kilogram of body weight), or saline (1.2 mL per kilogram of body weight), within 2 weeks and were sacrificed 5 days or 5 weeks after the last injection. IENFD was determined with protein gene product (PGP) 9.5 immunofluorescent staining and blinded and automated image analysis. The gadolinium and GBCA concentrations were measured with inductively coupled plasma mass spectrometry (ICP-MS), laser ablation ICP-MS, and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI). P values were calculated using linear contrasts of model analysis. Results The IENFD (measured as geometric mean [SD] and in number of nerve fibers per millimeter of epidermis) was not significantly altered after 5 days (saline, 8.4 [1.1]; gadobutrol, 9.7 [1.2]; gadoterate, 9.2 [1.2]; gadoteridol, 9.9 [1.3]; gadodiamide, 10.5 [1.2]) or 5 weeks (saline, 19.7 [1.4]; gadobutrol, 16.4 [1.6]; gadoterate, 14.3 [1.6]; gadoteridol, 22.2 [1.8]; gadodiamide, 17.9 [1.4]). Gadolinium skin concentrations were highest for gadodiamide after 5 days (16.0 nmol/g [1.1]) and 5 weeks (10.6 nmol/g [1.2], -33%). Macrocyclic agents were lower at 5 days (gadoteridol, 2.6 nmol/g [1.2]; gadobutrol, 2.7 nmol/g [1.1]; and gadoterate, 2.3 nmol/g [1.2]) and efficiently cleared after 5 weeks (gadoteridol, -95%; gadobutrol and gadoterate, -96%). The distribution of gadolinium and IENF did not visually overlap. For macrocyclic agents, gadolinium was found in sweat glands and confirmed to be intact chelate. Conclusion There were no signs of SFN in rat foot pads using multiple dosing regimens at two time points after administration of GBCAs. Macrocyclic GBCAs exhibited lower levels of gadolinium in the skin and were effectively eliminated within 5 weeks compared with linear gadodiamide, and intact macrocyclic GBCA was detected in sweat glands. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Clement in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Boyken J, Lohrke J, Treu A, et al. Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy. Radiology. 2024. PMID: 38226877. doi:10.1148/radiol.231984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。